The purpose of this study is to determine the clinical application of advanced ophthalmic imaging devices such as optical coherence tomography (OCT), retinal function imager (RFI), slit-lamp biomicroscopy (SLB), PERG in diseased eyes and normal controls. There are two phases in this study. The first phase is an observational phase which studies the eye in various conditions. The second phase is an interventional phase which studies the changes in the eyes after taking an over-the-counter medical food (Ocufolin) for 6 months.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Retinal microstructure using OCT.
Timeframe: up to 2 years
Retinal vasculature by optical coherence tomography angiography (OCTA)
Timeframe: up to 2 years
Conjunctival vasculature by functional slit-lamp (FSLB)
Timeframe: up to 2 years
Corneal epithelial thickness
Timeframe: up to 2 years
Tear film thickness
Timeframe: up to 2 years